Salzburg, Austria

Peter Lackner

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Biomay Ag. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Lackner. Retrieved from https://idiyas.com/inventor/peter-lackner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Lackner

Introduction

Peter Lackner is an accomplished inventor based in Salzburg, Austria. He is known for his significant contributions to the field of hypoallergenic molecules. With a focus on improving allergy treatments, his work has the potential to benefit many individuals suffering from allergies.

Latest Patents

Peter Lackner holds a patent for hypoallergenic molecules. The present invention relates to a hypoallergenic molecule consisting of Bet v Ia or an allergen having at least 40% identity to Bet v Ia. This invention comprises mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen having at least 40% identity to Bet v Ia. This innovative approach aims to reduce allergic reactions and improve the quality of life for allergy sufferers.

Career Highlights

Throughout his career, Peter Lackner has worked with notable organizations, including Biomay AG and Paris-Lodron-Universität Salzburg. His experience in these institutions has allowed him to develop and refine his research in the field of hypoallergenic molecules.

Collaborations

Peter has collaborated with talented individuals such as Nicole Wopfner and Michael Wallner. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Peter Lackner's innovative work in hypoallergenic molecules showcases his dedication to improving allergy treatments. His contributions to the field are significant and have the potential to make a lasting impact on the lives of many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…